A. E. Mamedov

489 total citations
13 papers, 344 citations indexed

About

A. E. Mamedov is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, A. E. Mamedov has authored 13 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in A. E. Mamedov's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (4 papers) and Immune Response and Inflammation (3 papers). A. E. Mamedov is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (4 papers) and Immune Response and Inflammation (3 papers). A. E. Mamedov collaborates with scholars based in Russia, Israel and France. A. E. Mamedov's co-authors include Markus Sutter, Martina Steiner, Eilika Weber‐Ban, Frank Imkamp, Frank Striebel, Alexander G. Gabibov, Maria Yu. Zakharova, Alexey A. Belogurov, И. С. Киселев and Sokolov Av and has published in prestigious journals such as The FASEB Journal, International Journal of Molecular Sciences and Nature Structural & Molecular Biology.

In The Last Decade

A. E. Mamedov

12 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Mamedov Russia 7 239 89 75 43 39 13 344
William Lin United States 9 158 0.7× 71 0.8× 66 0.9× 16 0.4× 49 1.3× 12 366
Erik Vernet Denmark 9 278 1.2× 44 0.5× 51 0.7× 39 0.9× 65 1.7× 17 405
Luisa Calvanese Italy 13 232 1.0× 36 0.4× 50 0.7× 25 0.6× 26 0.7× 32 358
Katharina Hötte Germany 7 238 1.0× 93 1.0× 107 1.4× 13 0.3× 20 0.5× 8 420
Pil‐Gu Park South Korea 11 233 1.0× 37 0.4× 74 1.0× 49 1.1× 8 0.2× 24 365
Larry Lantz United States 6 107 0.4× 167 1.9× 32 0.4× 71 1.7× 28 0.7× 8 368
Arjen van den Berg United States 9 374 1.6× 99 1.1× 39 0.5× 10 0.2× 29 0.7× 13 521
Quen J. Cheng United States 10 384 1.6× 146 1.6× 58 0.8× 25 0.6× 5 0.1× 14 585
Michelle Brault United States 7 314 1.3× 173 1.9× 83 1.1× 46 1.1× 18 0.5× 8 430
Hyein Jung South Korea 6 289 1.2× 64 0.7× 36 0.5× 41 1.0× 13 0.3× 12 393

Countries citing papers authored by A. E. Mamedov

Since Specialization
Citations

This map shows the geographic impact of A. E. Mamedov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Mamedov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Mamedov more than expected).

Fields of papers citing papers by A. E. Mamedov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Mamedov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Mamedov. The network helps show where A. E. Mamedov may publish in the future.

Co-authorship network of co-authors of A. E. Mamedov

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Mamedov. A scholar is included among the top collaborators of A. E. Mamedov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Mamedov. A. E. Mamedov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mamedov, A. E., Е. И. Шрамова, Sergey M. Deyev, et al.. (2024). Genetically engineered CD80–pMHC-harboring extracellular vesicles for antigen-specific CD4+ T-cell engagement. Frontiers in Bioengineering and Biotechnology. 11.
2.
Zakharova, Maria Yu., et al.. (2023). MHC Class II Presentation in Autoimmunity. Cells. 12(2). 314–314. 38 indexed citations
3.
Nersisyan, Stepan, et al.. (2022). Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules. PeerJ. 10. e13354–e13354. 16 indexed citations
4.
5.
Mamedov, A. E., Nadezhda E. Vorobyeva, И. С. Киселев, et al.. (2020). Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides. Frontiers in Immunology. 10. 3088–3088. 14 indexed citations
6.
Zakharova, Maria Yu., et al.. (2020). Exhaustive Search of the Receptor Ligands by the CyCLOPS (Cytometry Cell-Labeling Operable Phage Screening) Technique. International Journal of Molecular Sciences. 21(17). 6258–6258. 6 indexed citations
7.
Mamedov, A. E., Maria Yu. Zakharova, О. О. Фаворова, et al.. (2019). Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis. Doklady Biochemistry and Biophysics. 485(1). 115–118. 2 indexed citations
8.
Zakharova, Maria Yu., et al.. (2019). The Contribution of Major Histocompatibility Complex Class II Genes to an Association with Autoimmune Diseases. Acta Naturae. 11(4). 4–12. 31 indexed citations
9.
Mamedov, A. E., Н. А. Пономаренко, Alexey A. Belogurov, & А. Г. Габибов. (2016). Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306–318 Loading to HLA-DR1. Bulletin of Experimental Biology and Medicine. 161(1). 92–95. 1 indexed citations
10.
Пономаренко, Н. А., S.D. Chatziefthimiou, I. N. Kurkova, et al.. (2014). Role of κ→λ light-chain constant-domain switch in the structure and functionality of A17 reactibody. Acta Crystallographica Section D Biological Crystallography. 70(3). 708–719. 18 indexed citations
11.
Belogurov, Alexey A., А. В. Степанов, I. V. Smirnov, et al.. (2012). Liposome‐encapsulated peptides protect against experimental allergic encephalitis. The FASEB Journal. 27(1). 222–231. 49 indexed citations
12.
Степанов, А. В., Alexey A. Belogurov, A. E. Mamedov, et al.. (2012). Therapeutic effect of mbp immunodominant peptides encapsulated in nanovehicles in the development of experimental autoimmune encephalomyelitis in DA rats. Russian Journal of Bioorganic Chemistry. 38(3). 266–273. 6 indexed citations
13.
Striebel, Frank, Frank Imkamp, Markus Sutter, et al.. (2009). Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes. Nature Structural & Molecular Biology. 16(6). 647–651. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Lin Breakdown of academic impact, for papers by Erik Vernet Breakdown of academic impact, for papers by Luisa Calvanese Breakdown of academic impact, for papers by Katharina Hötte Breakdown of academic impact, for papers by Pil‐Gu Park Breakdown of academic impact, for papers by Larry Lantz Breakdown of academic impact, for papers by Arjen van den Berg Breakdown of academic impact, for papers by Quen J. Cheng Breakdown of academic impact, for papers by Michelle Brault Breakdown of academic impact, for papers by Hyein Jung
Rankless by CCL
2026